EARLY GASTRIC CANCER: THE MODERN OPINION

The review presents the clinical and morphological characteristics of early gastric cancer. According to the most recent concepts, early gastric cancer is considered as endoscopically resectable cancer with good prognosis. Currently, early gastric cancer is defined as non-invasive high-grade intraepithelial neoplasia (severe dysplasia) and well-differentiated adenocarcinoma with intramucosal (T1a) and/or minor submucosal (T1b1) invasion as well as poorly cohesive carcinoma, including signet-ring cell carcinoma, confined to the gastric mucosa (≤ 3 cm) without ulceration. Most authors consider that early gastric cancer should be characterized by the absence of regional lymph nodes (N0) and distant metastasis (M0). Early gastric cancer should be classified according to the macroscopic criteria proposed by the Japanese Society of Gastroenterological Endoscopy or the revised version of the Paris classification of superficial neoplastic lesions in the digestive tract as well as according to the World Health Organization classification and the recommendations of the Japanese Gastric Cancer Association. It is important to evaluate lymphovascular invasion in all early gastric cancer cases because of high risk of local metastases. Moreover, cases with mixed-type early gastric cancer (differentiated and undifferentiated components) need to be carefully examined, as they are high-metastatic potential lesions. The review considers predictive criteria for assessing the risk of regional metastasis in early gastric cancer. Cases of hereditary diffuse gastric cancer caused by CDHI gene mutations have been also analyzed. A literature review have allowed us to give recommendations on the risk stratification and the choice of an adequate treatment in patients with early gastric cancer

early gastric cancer, definition, classification, carcinoma in situ, high-grade dysplasia, intraepithelial neoplasia

1. Kolobaev I.V. The optimal extent of lymph node dissection for early gastric cancer [PhD thesis]. [Moscow]. 2009. 105. [in Russian]

2. Turkin I.N., Davydov М.I. What does determine the extent of lymph node dissection for early gastric cancer? Siberian Journal of Oncology. 2013; 2(56): 12–17. [in Russian]

3. Skoropad V.Yu., Berdov B.A. Early gastric cancer (pT1): clinical and morphological characteristics and surgical treatment outcomes. Annals of Surgery. 2003; 4: 30–36. [in Russian]

4. Lambert R. Participants in the Paris Workshop. The Paris endoscopic classification of superficial neoplastic lesions: esophagus, stomach, and colon: November 30 to December 1, 2002. Gastrointest. Endosc. 2003; 58 (6 Suppl): S3–43.

5. Hatta W., Gotoda T., Oyama T., Kawata N., Takahashi A., Yoshifuku Y., Hoteya S., Nakagawa M., Hirano M., Esaki M., Matsuda M., Ohnita K., Yamanouchi K., Yoshida M., Dohi O., Takada J., Tanaka K., Yamada S., Tsuji T., Ito H., Hayashi Y., Nakaya N., Nakamura T., Shimosegawa T. A Scoring System to Stratify Curability after Endoscopic Submucosal Dissection for Early Gastric Cancer: “eCura system”. Am J Gastroenterol. 2017 Jun; 112 (6): 874–881. doi: 10.1038/ajg.2017.95.

6. Gotoda T., Yanagisawa A., Sasako M., Ono H., Nakanishi Y., Shimoda T., Kato Y. Incidence of lymph node metastasis from early gastric cancer: estimation with a large number of cases at two large centers. Gastric Cancer. 2000 Dec; 3 (4): 219–225.

7. Isozaki H., Okajima K., Ichiinona T., Fujii K., Nomura E., Izumi N., Ohyama T. Distant lymph node metastasis of early gastric cancer. Surg. Today. 1997; 27 (7): 600–605.

8. Abe S., Oda I., Nakajima T., Suzuki H., Nonaka S., Yoshinaga S., Sekine S., Taniguchi H., Kushima R., Iwasa S., Saito Y., Katai H. A case of local recurrence and distant metastasis following curative endoscopic submucosal dissection of early gastric cancer. Gastric Cancer. 2015; 18 (1): 188–192. doi: 10.1007/s10120-014-0341-7.

9. Han S., Hsu A., Wassef W.Y. An update in the endoscopic management of gastric cancer. Curr Opin Gastroenterol. 2016; 32 (6): 492–500.

10. Cesaretti M., Zarzavadjian L.E., Bian A. In vivo medical imaging technologies: new possibility in diagnosis of gastric cancer. Minerva Chir. 2016; 71 (4): 270–277.

11. Sumiyama K. Past and current trends in endoscopic diagnosis for early stage gastric cancer in Japan. Gastric Cancer. 2017; 20 (S1): 20–27. doi: 10.1007/s10120-016-0659-4.

12. Murakami T., Iwanami E., Yasui A., Watanabe H., Chai S. The newest problems in the diagnosis of early stomach cancer. Rinsho Geka. 1962 May; 17: 321–30.

13. Yoshimori M. The natural history of early gastric cancer. Jpn. J. Clin. Oncol. 1989; 19 (2): 89–93.

14. Japanese Gastric Cancer Association. Japanese gastric cancer treatment guidelines 2014 (ver. 4). Gastric Cancer. 2017 Jan; 20 (1): 1–19. doi: 10.1007/s10120-016-0622-4.

15. Ajani J.A., D’Amico T.A., Almhanna K., Bentrem D.J., Chao J., Das P., Denlinger C.S., Fanta P., Farjah F., Fuchs C.S., Gerdes H., Gibson M., Glasgow R.E., Hayman J.A., Hochwald S., Hofstetter W.L., Ilson D.H., Jaroszewski D., Johung K.L., Keswani R.N., Kleinberg L.R., Korn W.M., Leong S., Linn C., Lockhart A.C., Ly Q.P., Mulcahy M.F., Orringer M.B., Perry K.A., Poultsides G.A., Scott W.J., Strong V.E., Washington M.K., Weksler B., Willett C.G., Wright C.D., Zelman D., McMillian N., Sundar H. Gastric cancer, version 3.2016, NCCN clinical practice guidelines in oncology. J Natl Compr Canc Netw. 2016; 14 (10): 1286–1312.

16. Tanabe S., Hirabayashi S., Oda I., Ono H., Nashimoto A., Isobe Y., Nunobe S. Gastric cancer treated by endoscopic submucosal dissection or endoscopic mucosal resection in Japan from 2004 through 2006: JGCA nationwide registry conducted in 2013. Gastric Cancer. 2017 Feb 15. doi: 10.1007/s10120-017-0699-4.

17. Barreto S.G., Windsor J.A. Redefining early gastric cancer. Surg Endosc. 2016 Jan; 30 (1): 24–37. doi: 10.1007/s00464-015-4184-z.

18. Peterson B.E., Chissov V.I., Avdeev G.I. Early oncological pathology. Ранняя онкологическая патология. Moscow; 1985: 320. [in Russian]

19. Endoscopic Classification Review Group. Update on the paris classification of superficial neoplastic lesions in the digestive tract. Endoscopy. 2005; 37 (6): 570–578.

20. Lee J.H., Min Y.W., Lee J.H., Kim E.R., Lee H., Min B.H., Kim J.J., Jang K.T., Kim K.M., Park C.K. Diagnostic group classifications of gastric neoplasms by endoscopic resection criteria before and after treatment: real-world experience. Surg Endosc. 2016 Sep; 30 (9): 3987–93. doi: 10.1007/s00464-015-4710-z.

21. Gotoda T., Iwasaki M., Kusano C., Seewald S., Oda I. Endoscopic resection of early gastric cancer treated by guideline and expanded National Cancer Centre criteria. Br J Surg. 2010 Jun; 97 (6): 868–71. doi: 10.1002/bjs.7033.

22. Hasuike N., Ono H., Boku N., Mizusawa J., Takizawa K., Fukuda H., Oda I., Doyama H., Kaneko K., Hori S., Iishi H., Kurokawa Y., Muto M., Gastrointestinal Endoscopy Group of Japan Clinical Oncology Group (JCOG-GIESG). A non-randomized confirmatory trial of an expanded indication for endoscopic submucosal dissection for intestinal-type gastric cancer (cT1a): the Japan Clinical Oncology Group study (JCOG0607). Gastric Cancer. 2017 Feb 21. doi: 10.1007/s10120-017-0704-y.

23. Kim Y.H., Kim J.H., Kim H., Kim H., Lee Y.C., Lee S.K., Shin S.K., Park J.C., Chung H.S., Park J.J., Youn Y.H., Park H., Noh S.H., Choi S.H. Is the recent WHO histological classification for gastric cancer helpful for application to endoscopic resection? Gastric Cancer. 2016 Jul; 19 (3): 869–75. doi: 10.1007/s10120-015-0538-4.

24. Lee I.S., Lee S., Park Y.S., Gong C.S., Yook J.H., Kim B.S. Applicability of endoscopic submucosal dissection for undifferentiated early gastric cancer: Mixed histology of poorly differentiated adenocarcinoma and signet ring cell carcinoma is a worse predictive factor of nodal metastasis. Surg Oncol. 2017 Mar; 26 (1): 8–12. doi: 10.1016/j.suronc.2016.12.001

25. Imamura T., Komatsu S., Ichikawa D., Kawaguchi T., Kosuga T., Okamoto K., Konishi H., Shiozaki A., Fujiwara H., Otsuji E. Early signet ring cell carcinoma of the stomach is related to favorable prognosis and low incidence of lymph node metastasis. J Surg Oncol. 2016 Oct; 114 (5): 607–612. doi: 10.1002/jso.24377.

26. Tan D., Lauwers G. Gastric Cancer. Lippincott Williams & Wilkins. 2011; 348.

27. Farinati F., Rugge M., Di Mario F., Valiante F., Baffa R. Early and advanced gastric cancer in the follow-up of moderate and severe gastric dysplasia patients. A prospective study. I.G.G.E.D.--Interdisciplinary Group on Gastric Epithelial Dysplasia. Endoscopy. 1993 May; 25 (4): 261–4.

28. Ryu D.G., Choi C.W., Kang D.H., Kim H.W., Park S.B., Kim S.J., Nam H.S. Clinical outcomes of endoscopic submucosa dissection for highgrade dysplasia from endoscopic forceps biopsy. Gastric Cancer. 2017 Jul; 20 (4): 671–678. doi: 10.1007/s10120-016-0665-6.

29. Fertitta A.M., Comin U., Terruzzi V., Minoli G., Zambelli A., Cannatelli G., Bodini P., Bertoli G., Negri R., Brunati S. Clinical significance of gastric dysplasia: a multicenter follow-up study. Gastrointestinal Endoscopic Pathology Study Group. Endoscopy. 1993; 25 (4): 265–268.

30. Borchardt H., Borrmann R., Christeller E., Dietrich A., Fischer W., Gierke E.V., Mayer E. Verdauungsschlauch: Dritter Teil. Softcover reprint of the original 1st ed. 1929 edition. Berlin: Springer. 2012; 1076.

31. Kajitani T. The general rules for the gastric cancer study in surgery and pathology. Jpn J Surg. 1981 Mar; 11 (2): 127–39.

32. Japanese Gastric Cancer Association. Japanese classification of gastric carcinoma: 3rd English edition. Gastric Cancer. 2011 Jun; 14 (2): 101–12. doi: 10.1007/s10120-011-0041-5.

33. Ohta H., Noguchi Y., Takagi K., Nishi M., Kajitani T., Kato Y. Early gastric carcinoma with special reference to macroscopic classification. Cancer. 1987 Sep 1; 60 (5): 1099–106.

34. Ohara Y., Toshikuni N., Matsueda K., Mouri H., Yamamoto H. The superficial elevated and depressed lesion type is an independent factor associated with non-curative endoscopic submucosal dissection for early gastric cancer. Surg Endosc. 2016; 30 (11): 4880–88.

35. Abe S., Oda I., Shimazu T., Kinjo T., Tada K., Sakamoto T., Kusano C., Gotoda T. Depth-predicting score for differentiated early gastric cancer. Gastric Cancer. 2011; 14 (1): 35–40.

36. Nakamura T., Yao T., Kakeji Y., Anai H., Morita M., Oda Y., Maehara Y. Depressed type of intramucosal differentiated-type gastric cancer has high cell proliferation and reduced apoptosis compared with the elevated type. Gastric Cancer. 2013 Jan; 16 (1): 94–9. doi: 10.1007/ s10120-012-0152-7.

37. Sobin L.Kh. TNM. Classification of malignant tumors. Moscow, 2011; 22. [in Russain]

38. Antonovich V.B. X-ray diagnosis of diseases of the esophagus, stomach, intestines. Moscow, 1987; 400. [in Russian]

39. Aruin L.I., Grigor’ev P.Ya., Isakov V.A., Yakovenko E.P. Chronic gastritis. Amsterdam, 1993; 362. [in Russian]

40. Park K., Jang G., Baek S., Song H. Usefulness of combined PET/ CT to assess regional lymph node involvement in gastric cancer. Tumori. 2014 Mar-Apr; 100 (2): 201–6. doi: 10.1700/1491.16415.

41. Park Y.M., Cho E., Kang H.Y., Kim J.M. The effectiveness and safety of endoscopic submucosal dissection compared with endoscopic mucosal resection for early gastric cancer: a systematic review and metaanalysis. Surg Endosc. 2011 Aug; 25 (8): 2666–77. doi: 10.1007/ s00464-011-1627-z.

42. Park J.H., Lee S.H., Park J.M., Park C.S., Park K.S., Kim E.S., Cho K.B. Prediction of the indication criteria for endoscopic resection of early gastric cancer. World J Gastroenterol. 2015 Oct 21; 21 (39): 11160–7. doi: 10.3748/wjg.v21.i39.11160.

43. Lauren P. The two histological main types of gastric carcinoma: diffuse and so-called intestinal-type carcinoma. An attempt at a histo-clinical classification. Acta Pathol Microbiol Scand. 1965; 64: 31–49.

44. Chen Y.C., Fang W.L., Wang R.F., Liu C.A., Yang M.H., Lo S.S., Wu C.W., Li A.F., Shyr Y.M. Huang K.H. Clinicopathological Variation of Lauren Classification in Gastric Cancer. Pathol Oncol Res. 2016 Jan; 22 (1): 197–202. doi: 10.1007/s12253-015-9996-6.

45. Bosman F.T., Carneiro F., Hruban R.H., Theise N.D. WHO classification of tumours of the digestive system. World Health Organization, Lyon: IARC Press, 2010; 417.

46. Lewin K.J., Appelmen H.D. Morphological variants of gastric adenocarcinoma. Tumors Esophagus Stomach. Armed Forces Inst. Pathol. Wash. DC. 1996; 313–317.

47. Everett S.M., Axon A.T.R. Early gastric cancer in Europe. Gut. 1997; 41 (2): 142–150.

48. Ming S.C. Gastric carcinoma. A pathobiological classification. Cancer. 1977; 39 (6): 2475–2485.

49. Nagayo T. Microscopical cancer of the stomach a study on histogenesis of gastric carcinoma. Int J Cancer. 1975 Jul 15; 16 (1): 52–60.

50. Grundmann E., Schlake W. Histological classification of gastric cancer from initial to advanced stages. Pathol Res Pract. 1982; 173 (3): 260–74.

51. Kodama Y., Inokuchi K., Soejima K., Matsusaka T., Okamura T. Growth patterns and prognosis in early gastric carcinoma. Superficially spreading and penetrating growth types. Cancer. 1983 Jan 15; 51 (2): 320–6.

52. Goseki N., Takizawa T., Koike M. Differences in the mode of the extension of gastric cancer classified by histological type: new histological classification of gastric carcinoma. Gut. 1992 May; 33 (5): 606–12.

53. Hamilton S.R., Aaltonen L.A. WHO classification of tumours. Pathology and genetics of tumours of the digestive system. Geneva WHO, IARC Press, Lyon 2000; 103–19.

54. Fang C., Shi J., Sun Q., Gold J.S., Xu G.F., Liu W.J., Zou X.P., Huang Q. Risk factors of lymph node metastasis in early gastric carcinomas diagnosed by WHO criteria in 379 Chinese patients. J Dig Dis. 2016; 17 (8): 526–537.

55. Huang Q., Fang C., Shi J., Sun Q., Wu H., Gold J.S., Weber H.C., Guan W., Zhang Y., Yu C., Zou X., Mashimo H. Differences in Clinicopathology of Early Gastric Carcinoma between Proximal and Distal Location in 438 Chinese Patients. Sci Rep. 2015 Aug 27; 5: 13439. doi: 10.1038/ srep13439.

56. Lee H.J., Kim G.H., Park D.Y., Lee B.E., Jeon H.K., Jhi J.H., Song G.A. Is endoscopic submucosal dissection safe for papillary adenocarcinoma of the stomach? World J. Gastroenterol. 2015; 21 (13): 3944–3952. doi: 10.3748/wjg.v21.i13.3944.

57. Huang Q., Zou X. Clinicopathology of Early Gastric Carcinoma: An Update for Pathologists and Gastroenterologists. Gastrointest Tumors. 2017 Mar; 3 (3–4): 115–124. doi: 10.1159/000456005.

58. Lee J.H., Choi I.J., Kook M.C., Nam B.H., Kim Y.W., Ryu K.W. Risk factors for lymph node metastasis in patients with early gastric cancer and signet ring cell histology. Br J Surg. 2010 May; 97 (5): 732–6. doi: 10.1002/bjs.6941.

59. Yoo C.H., Park S.J., Park M.I., Moon W., Kim H.H., Lee J.S., Song J.Y., Jang H.K. Submucosal tumor-like early-stage mucinous gastric carcinoma: a case study. Korean J Gastroenterol. 2013 Aug 25; 62 (2): 122–5.

60. Adachi Y., Yasuda K., Inomata M., Shiraishi N., Kitano S., Sugimachi K. Clinicopathologic study of early-stage mucinous gastric carcinoma. Cancer. 2001 Feb 15; 91 (4): 698–703.

61. Caruso R.A. The histogenesis of mucinous adenocarcinoma of the stomach from observations in early gastric cancer. Ann Diagn Pathol. 1999 Jun; 3 (3): 160–4.

62. Fang W.L., Wu C.W., Lo S.S., Chen J.H., Hsieh M.C., Shen K.H., Li A.F., Tai L.C., Lui W.Y. Mucin-producing gastric cancer: clinicopathological difference between signet ring cell carcinoma and mucinous carcinoma. Hepatogastroenterology. 2009 Jul-Aug; 56 (93): 1227–31.

63. Shin D.H., Kim G.H., Lee B.E., Lee J.W., Ha D.W., Jeon H.K., Baek D.H., Song G.A., Ahn S.J., Park D.Y. Clinicopathologic features of early gastric carcinoma with lymphoid stroma and feasibility of endoscopic submucosal dissection. Surg Endosc. 2017 Apr 13. doi: 10.1007/ s00464-017-5470-8.

64. Lim H., Lee I.S., Lee J.H., Park Y.S., Kang H.J., Na H.K., Ahn J.Y., Kim D.H., Choi K.D., Song H.J., Lee G.H., Jung H.Y., Kim J.H., Kim B.S., Yook J.H., Kim B.S. Clinical application of early gastric carcinoma with lymphoid stroma based on lymph node metastasis status. Gastric Cancer. 2017 Feb 15. doi: 10.1007/s10120-017-0703-z.

65. Huh C.W., Jung D.H., Kim H., Kim H., Youn Y.H., Park H., Kim J.W., Choi S.H., Noh S.H., Kim J.H. Clinicopathologic features of gastric carcinoma with lymphoid stroma in early gastric cancer. J Surg Oncol. 2016 Nov; 114 (6): 769–772. doi: 10.1002/jso.24385.

66. Lim J.H., Kim S.G., Choi J., Im J.P., Kim J.S., Jung H.C. Risk factors for synchronous or metachronous tumor development after endoscopic resection of gastric neoplasms. Gastric Cancer. 2015; 18 (4): 817–823. doi: 10.1007/s10120-014-0438-z.

67. Kim Y.H., Park J.H., Park C.K., Kim J.H., Lee S.K., Lee Y.C., Noh S.H., Kim H. Histologic purity of signet ring cell carcinoma is a favorable risk factor for lymph node metastasis in poorly cohesive, submucosa-invasive early gastric carcinoma. Gastric Cancer. 2017 Jul; 20 (4): 583–590. doi: 10.1007/s10120-016-0645-x.

68. Pyo J.H., Lee H., Min B.H., Lee J.H., Choi M.G., Lee J.H., Sohn T.S., Bae J.M., Kim K.M., Yeon S., Jung S.H., Kim J.J., Kim S. Early gastric cancer with a mixed-type Lauren classification is more aggressive and exhibits greater lymph node metastasis. J Gastroenterol. 2017; 52 (5): 594–601. doi: 10.1007/s00535-016-1254-5.

69. Pyo J.H., Ahn S., Lee H., Min B.H., Lee J.H., Shim S.G., Choi M.G., Lee J.H., Sohn T.S., Bae J.M., Kim K.M., Yeon S., Jung S.H., Kim J.J., Kim S. Clinicopathological Features and Prognosis of Mixed-Type T1a Gastric Cancer Based on Lauren’s Classification. Ann Surg Oncol. 2016 Dec; 23 (Suppl 5): 784–91.

70. Hwang C.S., Ahn S., Lee B.E., Lee S.J., Kim A., Choi C.I., Kim D.H., Jeon T.Y., Kim G.H., Song G.A., Park D.Y. Risk of lymph node metastasis in mixed-type early gastric cancer determined by the extent of the poorly differentiated component. World J. Gastroenterol. 2016; 22 (15): 4020–6. doi: 10.3748/wjg.v22.i15.4020.

71. Han J.P., Hong S.J., Kim H.K. Long-term outcomes of early gastric cancer diagnosed as mixed adenocarcinoma after endoscopic submucosal dissection. J Gastroenterol Hepatol. 2015 Feb; 30 (2): 316–20. doi: 10.1111/jgh.12838.

72. Park H.K., Lee K.Y., Yoo M.W., Hwang T.S., Han H.S. Mixed Carcinoma as an Independent Prognostic Factor in Submucosal Invasive Gastric Carcinoma. J Korean Med Sci. 2016 Jun; 31 (6): 866–72. doi: 10.3346/jkms.2016.31.6.866.

73. Shim C.N., Chung H., Park J.C., Lee H., Shin S.K., Lee S.K., Lee Y.C. Early gastric cancer with mixed histology predominantly of differentiated type is a distinct subtype with different therapeutic outcomes of endoscopic resection. Surg Endosc. 2015 Jul; 29 (7): 1787–94. doi: 10.1007/s00464-014-3861-7.

74. Carriaga M.T., Henson D.E. The histologic grading of cancer. Cancer. 1995; 75 (1): 406–421.

75. Saragoni L., Gaudio M., Morgagni P., Folli S., Vio A., Scarpi E., Saragoni A. The role of growth patterns, according to Kodama’s classification, and lymph node status, as important prognostic factors in early gastric cancer: analysis of 412 cases. Gastric Cancer. 2000 Dec 27; 3 (3): 134–140.

76. Saragoni L., Morgagni P., Gardini A., Marfisi C., Vittimberga G., Garcea D., Scarpi E. Early gastric cancer: diagnosis, staging, and clinical impact. Evaluation of 530 patients. New elements for an updated definition and classification. Gastric Cancer. 2013 Oct; 16 (4): 549–54. doi: 10.1007/ s10120-013-0233-2.

77. Zhao B.W., Chen Y.M., Jiang S.S., Chen Y.B., Zhou Z.W., Li Y.F. Lymph Node Metastasis, a Unique Independent Prognostic Factor in Early Gastric Cancer. PLoS One. 2015 Jul 8; 10 (7): e0129531. doi: 10.1371/ journal.pone.0129531.

78. Belous T.A. Clinical morphology of the initial stomach cancer. [Abstract of PhD thesis]. [Moscow]: 1998; 180. [in Russian]

79. Sekiguchi M., Oda I., Taniguchi H., Suzuki H., Morita S., Fukagawa T., Sekine S., Kushima R., Katai H. Risk stratification and predictive risk-scoring model for lymph node metastasis in early gastric cancer. J. Gastroenterol. 2016; 51 (10): 961–970. doi: 10.1007/s00535-016-1180-6.

80. Monahan K.J., Hopkins L. Diagnosis and Management of Hereditary Gastric Cancer. Recent Results Cancer Res. 2016; 205: 45–60. doi: 10.1007/978-3-319-29998-3_4.

81. Brandão C., Dinis-Ribeiro M. Early diagnosis of hereditary diffuse gastric cancer: (not only) an endoscopic challenge! Endosc Int Open. 2016 Dec; 4 (12): E1311E1312.

82. Fujita H., Lennerz J.K., Chung D.C., Patel D., Deshpande V., Yoon S.S., Lauwers G.Y. Endoscopic surveillance of patients with hereditary diffuse gastric cancer: biopsy recommendations after topographic distribution of cancer foci in a series of 10 CDH1-mutated gastrectomies. Am J Surg Pathol. 2012 Nov; 36 (11): 1709–17. doi: 10.1097/ PAS.0b013e31826ca204.

83. Fitzgerald R.C., Hardwick R., Huntsman D., Carneiro F., Guilford P., Blair V., Chung D.C., Norton J., Ragunath K., Van Krieken J.H., Dwerryhouse S., Caldas C.; International Gastric Cancer Linkage Consortium. Hereditary diffuse gastric cancer: updated consensus guidelines for clinical management and directions for future research. J Med Genet. 2010 Jul; 47 (7): 436–44. doi: 10.1136/jmg.2009.074237.

84. Hüneburg R., Marwitz T., van Heteren P., Weismüller T.J., Trebicka J., Adam R., Nattermann J. Chromoendoscopy in combination with random biopsies does not improve detection of gastric cancer foci in CDH1 mutation positive patients. Endosc. Int. Open. 2016; 04 (12): E1305–E1310